Chemours received a Zacks Rank #4 (Sell) rating, ranks in the bottom 33% of its industry, and has experienced significant downward analyst revisions with earnings estimates cut by more than 46% (from 49 cents to 26 cents per share) over 60 days. No analysts increased estimates during this period.
Company reduced full-year EBITDA guidance by $25-75 million, management admitted to channel oversupply and misallocation of $65 million in sales, and stock price declined 18.63%. Securities fraud investigation initiated by law firm raises concerns about potential disclosure violations and investor losses.
Pomerantz LLP is investigating claims on behalf of investors, suggesting potential legal issues or investor harm.
Stock plunged 18.7% following Q2 earnings that missed revenue expectations and showed a significant 31% decline in adjusted EPS. Primary headwinds include lower refrigerant sales due to channel inventory and loss of the SPS Capstone business line. However, the negative sentiment is partially tempered by management's maintained growth guidance, recent price increases, and growing AI data center business, which could appeal to value investors at current valuations (11x adjusted earnings).
Called a highest-conviction name in the chemicals layer with strong year-to-date performance (up 88%). Positioned as underappreciated beneficiary of AI buildout.
Two-phase fluid supplier into the cooling stack; positioned to benefit from massive thermal management market expansion
Articles that tag CC but are mainly about other companies.
Major fluoropolymer manufacturer positioned to benefit from strong market growth driven by semiconductor, EV, and battery demand; included in competitive landscape analysis of key industry players
Listed as a major player in the glycolic acid market, positioned to benefit from the projected 8.06% CAGR growth through 2035.
Chemours is identified as a key market player in North America and recently introduced advanced Opteon HFO-based blowing agent formulations, demonstrating innovation aligned with regulatory compliance and market trends.
As a major fluoropolymer producer, the company benefits from projected 6.5% CAGR market growth driven by EV adoption, semiconductor demand, and renewable energy expansion through 2030.
Listed as a key player in the growing micronized PTFE market, which is projected to expand at 5.2% CAGR through 2030 with strong demand across multiple industries.
Titanium dioxide producer positioned to benefit from sulfur shortage-driven pricing support in titanium dioxide markets
Key market player positioned to benefit from strong growth in liquid cooling fluids demand driven by AI and cloud computing expansion.
Significant fluoropolymers manufacturer positioned to capitalize on market expansion driven by automotive, aerospace, and electronics demand
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
